ClinicalTrials.govpublic full text
Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
malignant pleural disease, mesothelioma, metastases, lung cancer, breast cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 311123
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.